510(k) · Cleared
ClearedBD Ultra-Fine™ Insulin Syringe, BD Ultra-Fine™ II Insulin Syringe, BD Insulin Syringes with the BD Ultra-Fine™ needle and BD Insulin Syringes with Micro-Fine™ IV Needle
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Becton Dickinson & Company · FMF Syringe, Piston
Cleared on Apr 12, 2017 as substantially equivalent to K941657 (Bd Becton Dickinson Vacutainer Systems Preanalytic, 1994) and 2 other predicates after a 63-day review. Its family tree reaches back 2 generations to 1994. 3 later devices descend from it.
- Decided
- Apr 12, 2017
- Review
- 63 days
- Class
- Class II
- Product code
- FMF
- Recalls
- None
- Predicates
- 3
Its longest line of descent runs back 2 generations to K941657 (1994). 3 ancestors in all. 3 later devices descend from it, 1 citing it directly.
- Root · 2 generations backK941657 BD Micro Fine, Ultra Fine, and Allergy SyringeBd Becton Dickinson Vacutainer Systems Preanalytic · 1994
- 1 generation backK024112 BD Insulin SyringeBecton, Dickinson & CO · 2003 · Recalled
- This deviceK170386 BD Ultra-Fine™ Insulin Syringe, BD Ultra-Fine™ II Insulin Syringe…Becton Dickinson & Company · 2017
- Descendant · cites it directly · 2 of its ownK190054 BD Insulin SyringeBecton, Dickinson and Company · 2019 · Recalled
- Descendant · 2 generations on · 0 of its ownK260208 Ultra-Fine™ SAFETY Insulin Syringeembecta Medical II, LLC · 2026
- Descendant · 2 generations on · 0 of its ownK212499 BD Insulin Syringe (0.3mL)Becton, Dickinson and Company · 2022
Most influential descendants
Showing 3 of 3 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K941657 | BD Micro Fine, Ultra Fine, and Allergy Syringe | Bd Becton Dickinson Vacutainer Systems Preanalytic | 1994 | — |
| −1 | K024112 | BD Insulin Syringe | Becton, Dickinson & CO | 2003 | 3 |
| 0 (this device) | K170386 | BD Ultra-Fine™ Insulin Syringe, BD Ultra-Fine™ II Insulin Syringe, BD Insulin… | Becton Dickinson & Company | 2017 | — |
| +1 | K190054 | BD Insulin Syringe | Becton, Dickinson and Company | 2019 | 8 |
| +2 | K260208 | Ultra-Fine™ SAFETY Insulin Syringe | embecta Medical II, LLC | 2026 | — |
| +2 | K212499 | BD Insulin Syringe (0.3mL) | Becton, Dickinson and Company | 2022 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1996 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2019 | 1 | 0 |
| 2022 | 1 | 0 |
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in FMF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new FMF device
- #1 K241821 Luer Lock Syringe with Safety Needle; Luer…score 16.1 · 8 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K941657 | BD Micro Fine, Ultra Fine, and Allergy SyringeSummary page 4…Class II, 21 CFR 880.5860 Product Code: FMF Legally marketed predicate devices to which substantial equivalence is being claimed: K941657: BD Ultra-Fine™ Insulin Syringe and BD Insulin Syringes with Micro-Fine™ IV Needle K955235: BD Ultra-Fine™ II Insulin Syr… | 1994 |
| * | K955235 | B-D Ultra Fine II, Micro Fine + Short Needle Insulin SyringeSummary page 4…dicate devices to which substantial equivalence is being claimed: K941657: BD Ultra-Fine™ Insulin Syringe and BD Insulin Syringes with Micro-Fine™ IV Needle K955235: BD Ultra-Fine™ II Insulin Syringe K024112: BD Insulin Syringes with the BD Ultra-Fine™ needle Device Description: The subje… | 1996 |
| * | K024112 | BD Insulin SyringeSummary page 4…is being claimed: K941657: BD Ultra-Fine™ Insulin Syringe and BD Insulin Syringes with Micro-Fine™ IV Needle K955235: BD Ultra-Fine™ II Insulin Syringe K024112: BD Insulin Syringes with the BD Ultra-Fine™ needle Device Description: The subject BD Insulin Syringes (BD Ultra-Fine™ Insulin… | 2003 |
What descends from it? (3)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K190054 | BD Insulin Syringe | 2019 | 2 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 23 years and passes through 3 companies; a new generation was cleared every 14.3 years on median.
- 2 of the 3 ancestors have a recall of any class.
- Of its descendants, K190054 (Becton, Dickinson and Company, 2019) has gone furthest, with 2 descendants of its own.
- 7 other devices also cite its predicate K941657.
How does its category compare?
All FMF devicesFMF Syringe, Piston: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.
FDA decisions per year · FMF
13in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · FMF
114in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · FMF
19in 2023
Class I (19 since 2007) Class II/III not classified
Adverse event reports per year · FMF
4,181in 2025
MAUDE reports naming product code FMF, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 23 | 90 | 6 | 674 |
| 2008 | 9 | 74 | 11 | 691 |
| 2009 | 14 | 94 | 15 | 913 |
| 2010 | 11 | 130 | 12 | 679 |
| 2011 | 16 | 109 | 3 | 186 |
| 2012 | 9 | 86 | 6 | 307 |
| 2013 | 12 | 154 | 1 | 326 |
| 2014 | 13 | 84 | 1 | 244 |
| 2015 | 11 | 87 | 2 | 273 |
| 2016 | 12 | 146 | 0 | 684 |
| 2017 | 13 | 135 | 3 | 1,858 |
| 2018 | 8 | 87 | 2 | 3,952 |
| 2019 | 11 | 146 | 1 | 5,863 |
| 2020 | 15 | 107 | 2 | 5,334 |
| 2021 | 20 | 175 | 1 | 5,874 |
| 2022 | 24 | 211 | 2 | 5,233 |
| 2023 | 22 | 173 | 19 (18) | 5,214 |
| 2024 | 14 | 130 | 0 | 5,122 |
| 2025 | 13 | 114 | 0 | 4,181 |
| 2026 | 9 | 239 | 2 (1) | — |
What is it indicated for?
Becton Dickinson insulin syringes are intended for subcutaneous injection of U100 insulin.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K170386 · printed Nov 6, 2026
Cite this page
510(k) Report. “K170386: BD Ultra-Fine™ Insulin Syringe, BD Ultra-Fine™ II Insulin Syringe, BD Insulin Syringes with the BD Ultra-Fine™ needle and BD Insulin Syringes with Micro-Fine™ IV Needle.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K170386
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026